Part 2 of our New Jersey Statutory Update focuses on bills approved during the second half of 2025.
To read Part 1 of our update, click here.
Coverage for Prosthetic Appliances
On July 8, 2025, the New Jersey Legislature approved Bill S1439, amending P.L.2007, c.345 (N.J.S.A. §§ 17:48-6ff, 17:48A-7cc, 17:48E-35.30, 17B:26-2.1z, 17B:27-46.1ff, 17B:27A-7.13, 17B:27A-19.17, 26:2J-4.31, and 52:14-17.29m), which mandates health benefits coverage for additional orthotic and prosthetic appliances. The Bill requires various health insurance providers to cover orthotic and prosthetic appliances, which support or replace body parts, when medically necessary. It also covers additional appliances for physical or recreational activities if a physician determines they are needed. These appliances may be obtained from licensed orthotists, prosthetists, podiatrists, or certified pedorthists.
The bill took effect on October 6, 2025. The full text of the bill can be found here.
Notice of Insulin Manufacturer Assistance Programs
On July 8, 2025, the New Jersey Legislature approved Bill S2886, supplementing P.L.2003, c.280 (codified at N.J.S.A. § 45:14-67.11), which requires pharmacies to inform individuals about insulin manufacturer assistance programs to help reduce the cost of insulin for individuals with diabetes. Pharmacies must prominently display information about available insulin manufacturer assistance programs on their websites and provide a pamphlet created by the Department of Health with this information upon request. Insulin manufacturers may notify the Department if they want to be included in these materials.
The bill takes effect on July 1, 2026. The full text of the bill can be found here.
Prohibition on Deceptive Marketing Practices
On August 11, 2025, the New Jersey Legislature approved Bill A3974, published as P.L.2025, c.122 (codified at N.J.S.A. §§ 56:8-230 et seq.), which establishes new restrictions on deceptive marketing practices by substance use disorder treatment providers. The bill prohibits providers offering substance use disorder treatment services from engaging in deceptive practices such as falsely claiming “in-network” or “out-of-network” status, giving misleading information about services or location, redirecting potential patients to other websites without consent, and asserting affiliations with other treatment providers without written permission.
Violations of the bill can result in civil fines up to $20,000 per violation and injured individuals have the right to legal action.
The bill took effect on August 11, 2025. The full text of the bill can be found here.
Criminal Penalties for Improper Referrals in Substance Use Disorder Treatment
On August 11, 2025, the New Jersey Legislature approved Bill A3973 amending P.L.2021, c.31 (N.J.S.A. § 2C:40A-6), which revises the current law that criminalizes certain payments for patient referrals to substance use disorder treatment facilities.
The bill makes it a third-degree crime for any healthcare provider, facility, organization, clinical laboratory, or recovery residence to give, solicit, offer, or receive payments or kickbacks in exchange for patient referrals to treatment facilities, recovery residences, or clinical laboratories. The bill also prohibits varying payments based on patient referrals, treatment duration, or the amount of insurance benefits.
Violations can result in restitution and a mandatory fine of $50,000. Additionally, the Department of Health and the Department of Community Affairs may suspend or revoke the applicable facility’s license or certification and impose penalties up to $20,000 per violation.
The bill took effect on August 11, 2025. The full text of the bill can be found here.
Reporting and Responsibility Under Employee Leasing Arrangements
On August 21, 2025, the New Jersey Legislature approved Bill S3773, amending P.L.2011, c.118 (N.J.S.A. § 34:8-68.1), which concerns requirements to report separations from employment under employee leasing agreements. The bill makes a “client company” solely responsible for the quality, adequacy, or safety of the goods or services produced or sold in the client company’s business; for directing, supervising, training, and controlling the work of the covered employees with respect to the business activities of the client company; for the acts, errors, or omissions of covered employees with regard to those activities; and for accurately reporting wages to the employee leasing company.
A client company is not responsible when the covered employee is acting under the express direction and control of the employee leasing company. The bill also requires a client company to comply with the reporting requirements concerning a separation of employment imposed on employers pursuant to N.J.S.A § 43:21-6(a) (regarding claims for benefits).
The bill took effect on August 21, 2025. The full text of the bill can be found here.
Option for Menopause-Related CME Credits for Physicians and Nurses
On December 19, 2025, the New Jersey Legislature approved Bill A5309, published as P.L.2025, c.175 (N.J.S.A. §§ 45:9-7.10 and 45:11-26.5), which permits up to three credits of continuing medical education (CME) on menopause to be used by nurses and physicians for license renewal. The credits are optional; however, providers who choose to complete the menopause and women’s health education programs shall receive CME credits toward their required CME credits for license renewal. These credits shall count toward the total CME hours required, which for physicians, includes a focus on patient safety, medical ethics, and other essential medical topics. The bill requires the Division of Consumer Affairs to promote awareness of the bill on its website.
The bill takes effect on June 17, 2026. The full text of the bill can be found here.
Analysis of Mental Health Service Needs, Including for Those Deaf and Hard of Hearing
On December 23, 2025, the New Jersey Legislature approved Bill S1067, published as P.L.2025, c.177, which directs the Department of Human Services (DHS) to conduct landscape analysis of available mental health services, including the need for access to mental health services for people who are deaf and hard of hearing. Within one year of the effective date, the Commissioner of DHS shall prepare and submit to the Governor and Legislature a written report setting forth the findings of the analysis conducted and any recommended policies, programs, or initiatives that may be undertaken to increase the state’s workforce of mental health professionals and support staff working in mental health settings, improve and promote access to care, and enhance the capacity of mental health professionals and support staff working in mental health settings for clients to meet the communication and cultural needs of clients.
Within six months of issuing the report, the Commissioner of DHS, in consultation with the Division of Consumer Affairs, shall, among other things, (1) identify best practices or recommended approaches for mental health professionals and support staff working in mental health settings related to the provision of culturally affirmative mental health services and linguistically appropriate mental health services, (2) develop or identify an existing evidence-based training or education program or programs concerning the provision of culturally affirmative mental health services and linguistically appropriate mental health services, and (3) make this information available on its website. The bill also requires the Commissioner to establish an advisory committee to make the recommendations and advice required by the bill.
The bill takes effect on March 23, 2026. The full text of the bill can be found here.